)
)
Precigen Investor Relations Material
Latest events
Q2 2024
Precigen
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Precigen Inc
Access all reports
Precigen Inc is an innovator in the discovery and development of next-generation gene and cell therapies, with a mission to enhance the lives of patients through transformational technologies. The company operates in two segments, Precigen, Inc. and Cell Therapy Systems (CTS). The Precigen, Inc. segment discovers and develops the next generation of gene and cellular therapies that address medical needs in cancer, infectious disease and immunological disorders.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
PGEN
Country
🇺🇸 United States